Overall, these results are consistent with the notion that MES-GSC-initiated brain tumours mount multiple vascular growth responses, either through vasectasia driven by EGFR (EGFR-EVs) or through angiogenesis, the latter dependent, at least in part, on the VEGF pathway. This evidence concerns the gene EGFR and brain neoplasm.